Article Details
Retrieved on: 2024-09-19 22:45:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ResMed faces a 3% drop in share price after concerns over Eli Lilly's Ozempic, which could impact the demand for CPAP machines in the sleep apnea ...
Article found on: www.ig.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here